Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Verona Pharma Plc ADR (NASDAQ: VRNA) was $33.11 for the day, down -2.22% from the previous closing price of $33.86. In other words, the price has decreased by -$2.22 from its previous closing price. On the day, 0.55 million shares were traded. VRNA stock price reached its highest trading level at $34.25 during the session, while it also had its lowest trading level at $33.05.
Ratios:
Our analysis of VRNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.61 and its Current Ratio is at 8.61. In the meantime, Its Debt-to-Equity ratio is 1.30 whereas as Long-Term Debt/Eq ratio is at 1.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on October 03, 2024, initiated with a Overweight rating and assigned the stock a target price of $50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 24 ’24 when Hahn Mark W sold 141,360 shares for $4.38 per share. The transaction valued at 618,761 led to the insider holds 13,672,560 shares of the business.
Hahn Mark W sold 3,200 shares of VRNA for $14,000 on Oct 25 ’24. The Chief Financial Officer now owns 13,669,360 shares after completing the transaction at $4.38 per share. On Oct 24 ’24, another insider, ZACCARDELLI DAVID, who serves as the President and CEO of the company, sold 140,000 shares for $4.38 each. As a result, the insider received 612,822 and left with 14,596,536 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRNA now has a Market Capitalization of 2774690816 and an Enterprise Value of 21235165184.
Stock Price History:
Over the past 52 weeks, VRNA has reached a high of $35.62, while it has fallen to a 52-week low of $11.39. The 50-Day Moving Average of the stock is 10.11%, while the 200-Day Moving Average is calculated to be 63.43%.
Shares Statistics:
VRNA traded an average of 1.03M shares per day over the past three months and 818330 shares per day over the past ten days. A total of 80.44M shares are outstanding, with a floating share count of 62.79M. Insiders hold about 22.56% of the company’s shares, while institutions hold 62.22% stake in the company. Shares short for VRNA as of 1728950400 were 7943446 with a Short Ratio of 7.73, compared to 1726185600 on 8849774. Therefore, it implies a Short% of Shares Outstanding of 7943446 and a Short% of Float of 10.209999999999999.
